2-Bromo-4-ethoxybutanoyl chloride | 443688-49-1

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 酰卤
• 英文名称: 2-Bromo-4-ethoxybutanoyl chloride
• CAS: 443688-49-1
• 化学式: C₆H₁₀BrClO₂
• 分子量: 229.501
• InChiKey: NWQQNGQSUQMOSF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-Bromo-4-ethoxybutanoyl chloride 在 三乙胺 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 生成 (2,6-Dimethoxyphenyl) 2-[bis(2-methoxyethyl)amino]-4-ethoxybutanoate
  参考文献：
  名称：

  具有静脉麻醉活性​​的新型水溶性2,6-二甲氧基苯基酯衍生物。

  摘要：

  发现许多水溶性的双氨基-2,6-二甲氧基苯基酯衍生物相对于异丙酚1在小鼠中表现出改善的麻醉活性。在所公开的类似物中，有44种在啮齿动物中被进一步谱图，并被发现是优于异丙酚的药剂。用于麻醉的诱导和维持。

  DOI：

  10.1016/s0960-894x(03)00346-9
• 作为产物：
  描述：

  4-ethoxybutanoic acid 在 吡啶 、 草酰氯 、 氢溴酸 、 溴 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 生成 2-Bromo-4-ethoxybutanoyl chloride
  参考文献：
  名称：

  具有静脉麻醉活性​​的新型水溶性2,6-二甲氧基苯基酯衍生物。

  摘要：

  发现许多水溶性的双氨基-2,6-二甲氧基苯基酯衍生物相对于异丙酚1在小鼠中表现出改善的麻醉活性。在所公开的类似物中，有44种在啮齿动物中被进一步谱图，并被发现是优于异丙酚的药剂。用于麻醉的诱导和维持。

  DOI：

  10.1016/s0960-894x(03)00346-9

文献信息

• Alanine 2, 6-dialkoxyphenyl ester derivatives as hypnotics
  申请人：——

  公开号：US20040059109A1

  公开（公告）日：2004-03-25

  The present invention relates to alanine 2,6-dialkoxyphenyl ester derivatives having the general formula I, Formula (I) wherein R 1 is (C 1-3 )alkyloxy, (C 1-3 )alkyloxy(C 1-3 )alkyl, (C 1-3 )alkylthio, (C 1-3 )alkylthio(C 1-3 )alkyl, (C 1-3 )alkylsulfinyl, (C 1-3 )alkylsulfinyl(C 1-3 )alkyl, (C 1-3 )alkylsulfonyl, (C 1-3 )alkylsulfonyl(C 1-3 )alkyl, (C 1-3 )alkyloxycarbonyl, (CH 2 ) n —CO—NR 8 R 9? or (CH2) n —NR 8 R 9?; n is 0, 1 or 2; R 2 is hydrogen or (C 1-3?)alkyl; R 3 is (C 1-3 )alkyl or (C 1-3 )alkyloxy(C 1-3?)alkyl; R 4 is (C 1-3 )alkyloxy(C 1-3 )alkyl; or R 3 and R 4 form together with the nitrogen atom to which they are bound a 5-, 6-, or 7-membered ring, optionally containing a further heteroatom selected from O and S, and which ring may optionally contain a double bond and be optionally substituted with (C 1-3 )alkyl or (C 1-3 )alkyloxy; R 5 and R 6 are independently (C 1-3 )alkyl; R 7 is hydrogen, (C 1-3 )alkyl, (C 1-3 )alkyloxy or (C 2-3 )alkenyl; R 8 and R 9 are independently (C 1-3 )alkyl; or R 8 and R 9 form together with the nitrogen atom to which they are bound a 5-, 6-, or 7-membered, optionally containing a further heteroatom selected from O and S, and which ring may optionally contain a double bond; or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said derivatives, and to the use of these alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics for the induction and maintenance of general anaesthesia. 1

  本发明涉及具有一般式I的丙氨酸2,6-二烷氧基苯酯衍生物，式(I)其中，R1是(C1-3)烷氧基、(C1-3)烷氧基(C1-3)烷基、(C1-3)烷基硫醚、(C1-3)烷基硫醚(C1-3)烷基、(C1-3)烷基亚磺酰、(C1-3)烷基亚磺酰(C1-3)烷基、(C1-3)烷基磺酰、(C1-3)烷基磺酰(C1-3)烷基、(C1-3)烷氧羰基、(CH2)n—CO—NR8R9或( )n—NR8R9；n为0、1或2；R2是氢或(C1-3)烷基；R3是(C1-3)烷基或(C1-3)烷氧基(C1-3)烷基；R4是(C1-3)烷氧基(C1-3)烷基；或R3和R4与它们所结合的氮原子一起形成一个5、6或7元环，可选地含有进一步从O和S中选择的杂原子，并且该环可以可选地含有双键并被(C1-3)烷基或(C1-3)烷氧基取代；R5和R6独立地是(C1-3)烷基；R7是氢、(C1-3)烷基、(C1-3)烷氧基或(C2-3)烯基；R8和R9独立地是(C1-3)烷基；或者R8和R9与它们所结合的氮原子一起形成一个5、6或7元环，可选地含有进一步从O和S中选择的杂原子，并且该环可以可选地含有双键；或其药学上可接受的盐。本发明还涉及包含上述衍生物的制药组合物，以及将这些丙氨酸2,6-二烷氧基苯酯衍生物用作诱导和维持全身麻醉的催眠药的用途。
• ALANINE 2,6-DIALKOXYPHENYL ESTER DERIVATIVES AS HYPNOTICS
  申请人：Akzo Nobel N.V.

  公开号：EP1373188B1

  公开（公告）日：2006-06-07
• US7141560B2
  申请人：——

  公开号：US7141560B2

  公开（公告）日：2006-11-28
• [EN] ALANINE 2,6-DIALKOXYPHENYL ESTER DERIVATIVES AS HYPNOTICS<br/>[FR] DERIVES D'ESTER 2,6-DIALCOXYPHENYL ALANINE COMME SOMNIFERES
  申请人：AKZO NOBEL NV

  公开号：WO2002057218A1

  公开（公告）日：2002-07-25

  The present invention relates to alanine 2,6-dialkoxyphenyl ester derivatives having the general formula I, Formula (I) wherein R1 is (C1-3)alkyloxy, (C1-3)alkyloxy(C1-3)alkyl, (C1-3)alkylthio, (C1-3)alkylthio(C1-3)alkyl, (C1-3)alkylsulfinyl, (C1-3)alkylsulfinyl(C1-3)alkyl, (C1-3)alkylsulfonyl, (C1-3)alkylsulfonyl(C1-3)alkyl, (C1-3)alkyloxycarbonyl, (CH2)n-CO-NR8R9 or (CH2)n-NR8R9; n is 0, 1 or 2; R2 is hydrogen or (C1-3)alkyl; R3 is (C1-3)alkyl or (C1-3)alkyloxy(C1-3)alkyl; R4 is (C1-3)alkyloxy(C1-3)alkyl; or R3 and R4 form together with the nitrogen atom to which they are bound a 5-, 6-, or 7- membered ring, optionally containing a further heteroatom selected from O and S, and which ring may optionally contain a double bond and be optionally substituted with (C1-3)alkyl or (C1-3)alkyloxy; R5 and R6 are independently (C1-3)alkyl; R7 is hydrogen, (C1-3)alkyl, (C1-3)alkyloxy or (C2-3)alkenyl; R8 and R9 are independently (C1-3)alkyl; or R8 and R9 form together with the nitrogen atom to which they are bound a 5-, 6-, or 7-membered, optionally containing a further heteroatom selected from O and S, and which ring may optionally contain a double bond; or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said derivatives, and to the use of these alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics for the induction and maintenance of general anaesthesia.